Vaxira

Monoclonal antibody indicated in treatment of patients with advanced non small cell lung cancer (NSCLC).

Therapeutic Area
Oncology

Active Ingredient
Racotumomab

Line
Oncology

Pharmaceutical Form
1 ampoule bottle with 1 mg solution

Download Leaflet Descargar